The prognosis for a patient with testicular cancer can be predicted based on multiple factors, including cancer sensitivity to the chemotherapy, the absence of metastases to the brain, liver, or bone, serum levels of AFP being lower than 1000 ng/mL, beta-hCG being either above or below 5000 mIU/mL, and LDH being either above or below three times the upper limit of normal levels. This evidence concerns the gene AFP and testicular cancer.